China Monogenic Diabetes Registry
Tianjin Medical University General Hospital
5,000 participants
Feb 28, 2021
OBSERVATIONAL
Conditions
Summary
This observational study aims to establish a digital registry, screening platform for patients with monogenic diabetes using internet-based and mobile application technologies. The primary objectives are to: Characterize the genetic landscape of monogenic diabetes in the Chinese population, including pathogenic variants and their distribution Participants will: * Enroll in the monogenic diabetes registry via mobile application or web-based platform * Undergo molecular genetic testing to establish a definitive diagnosis
Eligibility
Inclusion Criteria3
- Diabetes diagnosed before 25 years of age; OR diabetes diagnosed before 35 years of age with ≥1 first-degree relative (parent, sibling, or offspring) diagnosed with diabetes before 40 years of age
- Body mass index (BMI) at diagnosis 28 kg/m²
- Negative glutamic acid decarboxylase antibody (GAD-Ab)
Exclusion Criteria2
- Secondary diabetes
- Active malignancy or history of malignant tumor within the past 5 years
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
No Interventions
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07492004